Family Peer Navigator for Early Psychosis for Black Families
Launched by WASHINGTON STATE UNIVERSITY · Mar 8, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new support program called the Family Peer Navigator, specifically aimed at helping Black families who have a loved one at risk of early psychosis. Psychosis is a mental health condition where a person might have trouble distinguishing between what is real and what isn't. The study will develop and test this program to make sure families can easily access the care they need and engage in specialized treatment early on.
To participate in this trial, you must be at least 18 years old, identify as Black or African American, and have a family member who shows signs that they might be at risk for psychosis. The study is currently looking for participants, and anyone who joins can expect to learn more about available resources, receive guidance, and be part of a supportive community. It’s important to know that family members who do not speak English, cannot understand the consent process, or have already been referred to care services are not eligible for this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. ≥ 18 years of age
- • 2. Identifies as Black/African American
- • 3. Loved one who meets criteria for risk of psychosis with a total score of ≥ 3 on the Prodromal Questionnaire- Brief Version
- Exclusion Criteria:
- • 1. Family members who cannot understand the consent process
- • 2. Non-English speaking adults
- • 3. Black/African American families referred to coordinated specialty care and who have already been determined eligible for services by providers.
About Washington State University
Washington State University (WSU) is a leading research institution committed to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, WSU leverages its diverse expertise across various fields, including medicine, engineering, and agriculture, to address pressing health challenges. The university's clinical trial programs aim to enhance patient outcomes and contribute to the development of new therapies and interventions. By fostering a culture of scientific inquiry and integrity, WSU strives to improve public health and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tacoma, Washington, United States
Seattle, Washington, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials